Quarterly report pursuant to sections 13 or 15(d)

Consolidated Statements of Cash Flows

v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Cash flows from operating activities    
Net loss $ (6,528) $ (1,702)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 197 209
Amortization of debt discount 712 418
Interest accrued 221  
Allowance for doubtful accounts   (11)
Stock-based compensation 66 69
Increase / (decrease) in fair value of derivative liabilities 21  
(Increase) / decrease in assets, net of effect of disposal of subsidiary:    
Accounts receivable (311) 708
Prepaid expenses and other current assets (46) (54)
Increase / (decrease) in liabilities, net of effect of disposal of subsidiary:    
Accounts payable (175) (70)
Accrued license fees (144) 239
Accrued compensation 156 (178)
Other liabilities and other items 229 (133)
Net cash used in operating activities (3,294) 317
Cash flows from investing activities    
Purchase of property and equipment (8) (4)
Cash used in acquisition of subsidiary (3,416)  
Cash acquired with acquisition of subsidiary 59  
Net cash used in investing activities (3,365) (4)
Cash flows from financing activities    
Issuance of shares for cash 1,000  
Net cash provided by financing activities 1,000  
Effect of exchange rate changes on cash and cash equivalents (3) 48
Net change in cash and cash equivalents (5,662) (273)
Cash and cash equivalents, beginning of period 8,799 845
Cash and cash equivalents, end of period 3,137 572
Supplemental disclosure of cash flow information:    
Taxes paid 28 5
Interest paid      
Noncash investing and financing activities:    
Contingency earn out on acquisition of subsidiary, net of discount (758)  
Acquisition of subsidiary 788  
Service provider
    
Adjustments to reconcile net loss to net cash used in operating activities:    
Issuance of common stock and warrants   84
Services
    
Adjustments to reconcile net loss to net cash used in operating activities:    
Issuance of common stock and warrants $ 2,308 $ 104